The genetic markers of Parkinson’s disease BCL2, TBP,and TAF1 exert greater regulatory influence on acylcarnitinemetabolism enzymes, while PARP1 equally affects enzymesinvolved in both amino acid and acylcarnitine metabolism(Fig. 1). The gene discussed is PARP1; the disease is Parkinson disease.